样式: 排序: IF: - GO 导出 标记为已读
-
An updated review of the use of omalizumab for the treatment of uncontrolled pediatric allergic asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Bradley E Chipps,Meghan Farrell Garcia,Kevin R Murphy,Tmirah Haselkorn
Asthma has been increasingly recognized as a heterogeneous disease; however, many patients with asthma suffer from allergic asthma. While inhaled corticosteroids and other inhalers have been integral in treating many symptoms of asthma, these medications do not completely address the underlying mechanism of the disease. Pediatric asthma imposes a substantial burden on patients and the healthcare system
-
Anti-IgE therapy in chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Krishan D Chhiba,Gayatri B Patel,Anju T Peters
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory condition characterized by type 2 (T2) immune responses with significant impacts on quality of life and healthcare costs. Local IgE production in nasal polyp tissue plays a key role in the T2 inflammatory cascade. Omalizumab, an anti-IgE monoclonal antibody, is an effective treatment for some patients with CRSwNP regardless
-
Making Sense of Adenosine Deaminase Variants and Their Clinical Implications. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Eyal Grunebaum,Robyn Loves,Donald B Kohn
-
COVID-19 in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post covid conditions, prevention strategies, and future directions. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Juliane Wurm,Nicole Ritz,Petra Zimmermann
The epidemiology of COVID-19 in children has evolved throughout the pandemic, with initially low infection rates rising significantly due to the emergence of the more transmissible Omicron variant. Adolescents, children from ethnic minorities and lower-income households, and those with obesity are at increased risk of contracting SARS-CoV-2 infection. The immune response in children leads to milder
-
The importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-14 Marat V Khodoun,Richard T Strait,Ashley Hall,Adrienne Stolfi,Fred D Finkelman
BACKGROUND IgG can mediate murine and human systemic anaphylaxis (SA). The roles of mast cells (MCs) and histamine in IgG-mediated anaphylaxis are controversial for mice and have not been studied in vivo for humans. We now investigate these issues. METHODS Actively or passively sensitized wild-type and immune-deficient mice were induced to develop anaphylaxis by i.v. antigen challenge. Anaphylaxis
-
Early-life Upper Airway Microbiota are Associated with Decreased Lower Respiratory Tract Infections. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-13 Susan Zelasko,Mary Hannah Swaney,Shelby Sandstrom,Kristine E Lee,Jonah Dixon,Colleen Riley,Lauren Watson,Jared J Godfrey,Naomi Ledrowski,Federico Rey,Nasia Safdar,Christine M Seroogy,James E Gern,Lindsay Kalan,Cameron Currie
Microbial interactions mediating colonization resistance play key roles within the human microbiome, shaping susceptibility to infection from birth. To gain insight into microbiome-mediated defenses and respiratory pathogen colonization dynamics, we sequenced and analyzed nasal (n=229) and oral (n=210) microbiomes with associated health/environmental data from our Wisconsin Infant Study Cohort at age
-
Developmental trajectories of atopic dermatitis with multi-omics approaches in the infant gut: COCOA birth cohort. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-13 Eun Lee,Jeong-Hyun Kim,So-Yeon Lee,Si Hyeon Lee,Yoon Mee Park,Hea Young Oh,Jeonghun Yeom,Hee-Sung Ahn,Hyun Ju Yoo,Bong-Soo Kim,Sun Mi Yun,Eom Ji Choi,Kun Baek Song,Min Jee Park,Kangmo Ahn,Kyung Won Kim,Youn Ho Shin,Dong In Suh,Joo Young Song,Soo-Jong Hong
BACKGROUND An understanding of the phenotypes and endotypes of atopic dermatitis (AD) is essential for developing precision therapies. Recent studies have demonstrated evidence for the gut-skin axis in AD. OBJECTIVE To determine the natural course and clinical characteristics of AD phenotypes and investigate their mechanisms based on multi-omics analyses. METHODS Latent class trajectory analysis was
-
Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-13 ,
Self-reported food allergies (FAs) affect approximately 8% of the US pediatric and approximately 10% of the adult population, which reflects potentially disproportionate increases among ethnically and racially minoritized groups. Multiple gaps and unmet needs exist regarding FA disparities. There is reported evidence of disparities in FA outcomes, and the FA burden may also be disproportionate in low-income
-
Mesenchymal stem cell-derived small extracellular vesicles restored nasal barrier function in allergic rhinitis via miR-143-GSK3β in human nasal epithelial cells. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-12 Meiqian Xu,Mei Ren,Xinyin Zhang,Wenxu Peng,Hao Li,Wenjing Liao,Jianlei Xie,Xiaowen Zhang
BACKGROUND The nasal epithelial barrier is the first line of defense against the deep entry of pathogens or aeroallergens, and is more critical in allergic rhinitis (AR). Restoring epithelial barrier dysfunction might be a promising strategy for AR. Recent studies reported that mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEV) potentially inhibit the inflammation response and
-
Profiling immune cell tissue niches in the spatial "omics" era. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Colin Yc Lee,James McCaffrey,Dominic McGovern,Menna R Clatworthy
Immune responses require complex, spatially-coordinated interactions between immune cells and their tissue environment. For decades, we have imaged tissue sections to visualise a limited number of immune-related macromolecules in situ, functioning as surrogates for cell types or processes of interest. However, this inevitably provides a limited snapshot of the tissue's immune landscape. Recent developments
-
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Stephan Weidinger,Andrew Blauvelt,Kim A Papp,Adam Reich,Chih-Hung Lee,Margitta Worm,Charles Lynde,Yoko Kataoka,Peter Foley,Xiaodan Wei,Wanling Wong,Anne-Catherine Solente,Christine Weber,Samuel Adelman,Sonya Davey,Fabrice Hurbin,Natalie Rynkiewicz,Karl Yen,John T O'Malley,Charlotte Bernigaud
BACKGROUND Amlitelimab, a fully human nondepleting monoclonal antibody targeting OX40 ligand on antigen-presenting cells, could prevent T-cell-driven inflammation seen in atopic dermatitis (AD). OBJECTIVE This trial evaluated the efficacy and safety of amlitelimab in adults with AD. METHODS In this 2-part, phase 2b, randomized, double-blinded placebo-controlled trial (NCT05131477), patients received
-
Implementation of the esophageal string test in clinical practice and research. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Shauna Schroeder,Cindy S Bauer,Benjamin L Wright
-
Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Naruhito Iwasaki,Julie A Poposki,Masanori Kidoguchi,Aiko Oka,Aiko I Klingler,Whitney W Stevens,Lydia A Suh,Junqin Bai,Anju T Peters,Leslie C Grammer,Kevin C Welch,Stephanie S Smith,David B Conley,Bruce S Bochner,Robert P Schleimer,Robert C Kern,Bruce K Tan,Atsushi Kato
BACKGROUND Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 (T2) inflammation. Recent studies, including our own, suggest that neutrophils are also elevated in T2 nasal polyps (NPs) and that elevated neutrophils display an activated phenotype. However, the actual roles of neutrophils in NP pathogenesis in T2 CRSwNP are still largely unclear. OBJECTIVE To reveal the roles
-
Booster vaccination normalizes postvaccination immunity in patients with severe asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Hitasha Rupani,Rekha Chaudhuri,David J Jackson,Helen Moyses,Ramesh J Kurukulaaratchy,Hans Michael Haitchi,Michael R Edwards,Sebastian L Johnston,Ratko Djukanovic
-
Impact of biologics on the immune response to mRNA COVID-19 vaccination in patients with asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Shu-Yi Liao,Barry Make,Michael E Wechsler
-
Association between allergic diseases and mental health conditions: an umbrella review. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Xianpeng Xu,Sha Li,Yingjie Chen,Xinxing Deng,Jiongke Li,Dajing Xiong,Hui Xie
BACKGROUND The mental health conditions of allergic diseases has been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review is to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research. METHODS We systematically searched
-
Prevalence and outcomes of cancer and treatment-associated toxicities for patients with Ataxia Telangiectasia. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Aimee Magnarelli,Qi Liu,Fan Wang,Xiao Peng,Jennifer Wright,Ninad Oak,Valerie Natale,Cynthia Rothblum-Oviatt,Maureen A Lefton-Greif,Sharon McGrath-Morrow,Thomas O Crawford,Matthew J Ehrhardt,Howard M Lederman,Richa Sharma
BACKGROUND Ataxia Telangiectasia (A-T) is a DNA repair disorder with cancer predisposition. OBJECTIVE Characterize the prevalence and outcomes of hematologic and solid cancers and treatment-associated toxicities in individuals with A-T. METHODS Data was retrospectively analyzed from the Johns Hopkins Ataxia Telangiectasia Clinical Center cohort. Cumulative incidence and standardized incidence ratios
-
Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 P Abigail Alvarado-Vazquez,Erika Mendez-Enriquez,Maya Salomonsson,Peter Kopac,Ana Koren,Urska Bidovec-Stojkovic,Sabina Škrgat,Oscar E Simonson,Valentyna Yasinska,Sven-Erik Dahlén,Gunnar Pejler,Christer Janson,Peter Korosec,Andrei Malinovschi,Jenny Hallgren
BACKGROUND Therapies targeting interleukin-5 (IL-5) or its receptor (IL-5Rα) are currently used to treat patients with severe eosinophilic asthma. OBJECTIVE To investigate the impact of anti-IL-5 and anti-IL-5Rα biological therapies on mast cells (MCs) and their progenitors. METHODS Surface IL-5Rα expression was investigated on MCs and their progenitors in mouse lungs and bone marrow, and in human
-
Unravelling the noise in pharmacokinetic studies of epinephrine: time to focus on cardiac output? J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Nandinee Patel,Lucy Hawkins,Paul J Turner
-
Integrative epidemiology and immuno-transcriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Javier S Cabrera-Perez,Vincent J Carey,Oreofe O Odejide,Sonal Singh,Thomas S Kupper,Shiv S Pillai,Scott T Weiss,Ayobami Akenroye
BACKGROUND There have been multiple reports of the anti-IL4Rα agent, dupilumab, as associated with the onset and/or progression of cutaneous T-cell lymphoma (CTCL). OBJECTIVE We sought to evaluate safety signals associated with dupilumab, with a focus on CTCL, and to evaluate possible underlying mechanism(s) for the potential association. METHODS First, we used the FDA pharmacovigilance database, FAERS
-
IL-9 sensitizes human Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Stefanie Schärli,Fabian Luther,Jeremy Di Domizio,Christina Hillig,Susanne Radonjic-Hoesli,Kathrin Thormann,Dagmar Simon,Amalie Thorsti Møller Rønnstad,Iben Frier Ruge,Blaine G Fritz,Thomas Bjarnsholt,Angela Vallone,Sanja Kezic,Michael P Menden,Lennart M Roesner,Thomas Werfel,Jacob P Thyssen,Stefanie Eyerich,Michel Gilliet,Nicole L Bertschi,Christoph Schlapbach
BACKGROUND T helper 2 (Th2) cells crucially contribute to the pathogenesis of atopic dermatitis (AD) by secreting high levels of IL-13 and IL-22. Yet, the upstream regulators that activate Th2 cells in AD skin remain unclear. IL-18 is a putative upstream regulator of Th2 cells as it is implicated in AD pathogenesis and has the capacity to activate T cells. OBJECTIVE To decipher the role of IL-18 in
-
Current status and future directions in Food Protein-Induced Enterocolitis Syndrome (FPIES): An NIAID Workshop Report. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Anna Nowak-Wegrzyn,Scott H Sicherer,Cem Akin,Sara Anvari,Lisa M Bartnikas,M Cecilia Berin,Theresa A Bingemann,Scott Boyd,Terri Brown-Whitehorn,Supinda Bunyavanich,Antonella Cianferoni,George du Toit,John E Fortunato,Jeffrey D Goldsmith,Marion Groetch,Stephanie A Leonard,Meenakshi Rao,Fallon Schultz,Julie M Schwaninger,Carina Venter,Amity Westcott-Chavez,Robert A Wood,Alkis Togias
Food Protein-Induced Enterocolitis (FPIES) is a non-IgE mediated GI food allergy characterized by delayed, protracted vomiting, accompanied by lethargy and pallor, usually 1-4 hours following ingestion of the food allergen. The pathophysiology of FPIES remains unknown and currently there are no diagnostic biomarkers available to assess disease activity or its resolution. Over the last two decades,
-
Effect of Mepolizumab in airway's remodelling in patients with late-onset severe asthma with an eosinophilic phenotype. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Kalliopi Domvri,Ioanna Tsiouprou,Petros Bakakos,Paschalis Steiropoulos,Konstantinos Katsoulis,Konstantinos Kostikas,Katerina M Antoniou,Andriana I Papaioannou,Nikoletta Rovina,Paraskevi Katsaounou,Theodora Papamitsou,Nicoleta Pastelli,Stavros Tryfon,Evangelia Fouka,Despoina Papakosta,Stelios Loukides,Konstantinos Porpodis
BACKGROUND Clinical trials and real-world experience have provided evidence for the clinical benefit of mepolizumab, an anti-IL-5 biologic, in severe asthma. However, limited data exists regarding the impact of mepolizumab on airway remodelling. OBJECTIVE We thus investigated the effect of mepolizumab on airway structural remodelling in patients treated for severe asthma in routine clinical care. METHODS
-
IgG4 and eosinophilic esophagitis: Bridging the knowledge gap. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Laura Franceschini,Alessandro Farsi
-
Newborn screening for SCID and severe T lymphocytopenia in Europe. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-05 Maartje Blom,Maarja Soomann,Pere Soler-Palacín,Anna Šedivá,Asbjørg Stray-Pedersen,Rolf Zetterström,Carsten Speckmann,Andrew R Gennery,Mirjam van der Burg
Initiation of newborn screening (NBS) programs in Europe dates back to the 1960s. One of the most recent expansions of NBS programs was the addition of severe combined immunodeficiency (SCID) based on detection of T-cell receptor excision circles (TRECs). In this review, we present an overview of the current situation in Europe. To avoid a biased overview based on only published results, a 37-item
-
Association of CD19+-Targeted Chimeric Antigen Receptor (CAR) T-cell Therapy with Hypogammaglobulinemia, Infection and Mortality. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-04 Natalia M Sutherland,Baijun Zhou,Lingxiao Zhang,Mei-Sing Ong,Joseph S Hong,Andrew Pak,Katherine J Liu,Matthew J Frigault,Marcela V Maus,Joshua A Hill,Kerry Reynolds,Jolan E Walter,Carlos A Camargo,Sara Barmettler
BACKGROUND CD19-targeted chimeric antigen receptor T-cell therapy (CAR-T therapy) has revolutionized the treatment of hematologic malignancies. As these cells target CD19+ receptors on B-cells, there is the potential for B-cell aplasia and hypogammaglobulinemia. Data on the degree and clinical significance of hypogammaglobulinemia are sparse. OBJECTIVE To evaluate hypogammaglobulinemia after CD19-targeted
-
Baseline Epitope-Specific IgE Profiles are Predictive of Sustained Unresponsiveness or High Threshold One-Year Post OIT in the POISED Trial. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-04 Maria Suprun,Ashley Sang Eun Lee,Robert Getts,Simon Peck,Sayantani B Sindher,Kari C Nadeau,R Sharon Chinthrajah,Stephen J Galli,Hugh Sampson
BACKGROUND Results from the POISED trial suggest that discontinuation of peanut oral immunotherapy can increase the risk of regaining clinical reactivity to peanut. OBJECTIVE We sought to determine whether those who achieved sustained unresponsiveness (SU) or sustained high threshold (SHT) have different baseline sequential epitope-specific (es-) IgE profiles than those who achieved transient desensitization
-
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-30 Sven F Seys,Sven Schneider,Joost de Kinderen,Sietze Reitsma,Carlo Cavaliere,Peter-Valentin Tomazic,Christina Morgenstern,Geoffrey Mortuaire,Martin Wagenmann,Giulia Bettio,Andrea Ciofalo,Zuzana Diamant,Julia Eckl-Dorna,Wytske J Fokkens,Clemens Holzmeister,Gert Mariën,Simonetta Masieri,Josje Otten,Kathrin Scheckenbach,Aldine Tu,Claus Bachert,
BACKGROUND Pivotal studies with dupilumab demonstrated clinically relevant improvements in nasal polyp score (NPS), symptom and quality of life scores in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). OBJECTIVE We evaluated the effectiveness of dupilumab in a large-scale CRSwNP cohort from 6 European tertiary care centres. METHODOLOGY NPS, SinoNasal Outcome Test (SNOT)-22 score, visual
-
Sensory neuroimmune signaling in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-29 Xiaobao Huang,Suiting Ao,Rui Xu,Xuemei Gao,Shiling Qi,Yarong Liang,Peiying Feng,Ruzeng Xue,Yingying Ren,Jiande Han,Fengxian Li,Coco Chu,Fang Wang
BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous reactions often triggered by medications. While the involvement of CD8+ T cells causing keratinocyte death is well recognized, the contribution of neural elements to the persistent skin inflammation has been largely overlooked. OBJECTIVE To investigate the potential neuroimmune regulation in
-
Eosinophil extracellular traps drive T follicular helper cell differentiation via VIRMA-dependent MAF stabilization in bullous pemphigoid. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-28 Shengxian Shen,Hui Fang,Xia Li,Yifan Zhou,Xin Tang,Haijun Miao,Liang Li,Jiaoling Chen,Ke Xue,Chen Zhang,Mengyang Chu,Bingyu Pang,Yaxing Bai,Hongjiang Qiao,Erle Dang,Shuai Shao,Gang Wang
BACKGROUND Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by the presence of pathogenic autoantibodies and a substantial influx of immune cells into skin lesions. However, the role of eosinophils in BP remains inadequately elucidated. OBJECTIVE We sought to determine the pathologic involvement of eosinophils and eosinophil extracellular traps (EETs) in BP. METHODS Human samples
-
Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general population. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-22 Hannes Lindahl,Fredrik Kahn,Åsa Nilsdotter-Augustinsson,Mats Fredrikson,Pontus Hedberg,Isabela Killander Möller,Lotta Hansson,Lisa Blixt,Sandra Eketorp Sylvan,Anders Österborg,Soo Aleman,Christina Carlander,Sofia Nyström,Peter Bergman
BACKGROUND It is thought that patients with inborn errors of immunity (IEI) are more susceptible to severe coronavirus disease 2019 (COVID-19) than the general population, but a quantification of this potential risk is largely missing. OBJECTIVE We assessed the impact of COVID-19 on patients with IEI. METHODS A nationwide cohort study was performed to estimate the relative risk (RR) for hospitalization
-
Defining the overlap between asthma and bronchiectasis: A call for consensus definition. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-21 Sang Hyuk Kim,Bumhee Yang,Kyung Hoon Min,Hyun Lee
-
Atopic dermatitis, food allergy, anaphylaxis, other atopic conditions. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-19 Michelle L Hernandez,Pedro Giavina Bianchi,Richard Lockey,Sarita U Patil
-
Evolution of the concept of immune dysregulation and current classification. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-18 Sarah E Henrickson
-
Gastroesophageal reflux disease, laryngopharyngeal reflux, and vocal cord dysfunction/Inducible laryngeal obstruction - overlapping conditions that impact asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-17 Amy A Eapen,Meera R Gupta,Richard F Lockey,Philip G Bardin,Alan P Baptist
Asthma is a chronic lung condition that may be affected by numerous medical comorbidities. Such comorbidities can influence the presentation and even the severity of asthma. Alternatively, asthma may be misdiagnosed as a comorbidity when symptoms overlap. Three medical conditions that commonly affect asthma management are gastroesophageal reflux disease (GERD), laryngopharyngeal reflux (LPR), and vocal
-
Role of DOCK8 in cytokine storm syndromes. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-17 Mingce Zhang,Remy R Cron,Niansheng Chu,Junior Nguyen,Scott M Gordon,Esraa M Eloseily,T Prescott Atkinson,Peter Weiser,Mark R Walter,Portia A Kreiger,Scott W Canna,Edward M Behrens,Randy Q Cron
BACKGROUND Cytokine storm syndromes (CSSs), including hemophagocytic lymphohistiocytosis (HLH), are increasingly recognized as hyperinflammatory states leading to multiorgan failure and death. Familial HLH in infancy results from homozygous genetic defects in perforin-mediated cytolysis by CD8 T lymphocytes and natural killer (NK) cells. Later-onset CSSs are often associated with heterozygous defects
-
A partial loss-of-function variant in STAT6 protects against type 2 asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-16 Katla Kristjansdottir,Gudmundur L Norddahl,Erna V Ivarsdottir,Gisli H Halldorsson,Gudmundur Einarsson,Kristbjorg Bjarnadottir,Gudrun Rutsdottir,Asgeir O Arnthorsson,Christian Erikstrup,Steinunn Gudmundsdottir,Kristbjorg Gunnarsdottir,Maria I Gunnbjornsdottir,Bjarni V Halldorsson,Hilma Holm,Dora Ludviksdottir,Bjorn R Ludviksson,Søren Brunak,Mie Topholm Bruun,Christina Mikkelsen,Susan Mikkelsen,Bitten
BACKGROUND Signal transducer and activator of transcription 6 (STAT6) is central to type 2 (T2) inflammation, and common noncoding variants at the STAT6 locus associate with various T2 inflammatory traits, including diseases, and its pathway is widely targeted in asthma treatment. OBJECTIVE We sought to test the association of a rare missense variant in STAT6, p.L406P, with T2 inflammatory traits,
-
Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-16 Alba Pérez-Pons,Ana Henriques,Teresa Contreras Sanfeliciano,María Jara-Acevedo,Paula Navarro-Navarro,Andrés C García-Montero,Iván Álvarez-Twose,Quentin Lecrevisse,Rafael Fluxa,Laura Sánchez-Muñoz,Carolina Caldas,Julio Pozo,Óscar González-López,Martín Pérez-Andrés,Andrea Mayado,Alberto Orfao
BACKGROUND Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT-mutated constitutively activated mast cells (MCs) that release MC mediators, which might act on the tumor microenvironment including other immune cells. OBJECTIVE To investigate the blood distribution of B-cell, plasma cell (PC), and antibody isotype compartments in patients with SM. METHODS We used
-
IL-4 and dendritic cells in atopic dermatitis: Old dogs learn new tricks. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-09 Donata Vercelli
-
The rs6967330 minor allele in CDHR3 is a significant risk factor for severe acute exacerbations in chronic rhinosinusitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-09 Sunny Palumbo,Joseph Irish,Nirushan Narendran,Debra A Stern,Sophia Volpe,Christopher H Le,Rebekah Starks,Anthony Bosco,Fernando D Martinez,Eugene H Chang
BACKGROUND Acute exacerbations of chronic rhinosinusitis (AECRS) are commonly triggered by rhinovirus (RV) infections with secondary bacterial infections. Risk factors for AECRS are not well understood. OBJECTIVE We sought to determine whether carriers of the minor allele rs6967330 (AA/AG) in the cadherin-related family member 3 (CDHR3) gene have an increased risk for RV infections in AECRS in vivo
-
Differential Tfh cell phenotypes distinguish IgE-mediated milk allergy from eosinophilic esophagitis in children. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-08 Daniel Lozano-Ojalvo,Xin Chen,Wajiha Kazmi,David Menchén-Martínez,Leticia Pérez-Rodríguez,Weslley Fernandes-Braga,Scott Tyler,Keith Benkov,Nanci Pittman,Joanne Lai,Hugh A Sampson,Maria Curotto de Lafaille,David Dunkin,M Cecilia Berin
BACKGROUND IgE-mediated food allergy and eosinophilic esophagitis (EoE) are diseases commonly triggered by milk. Milk-responsive CD4+ T cells producing type 2 cytokines are present in both diseases, yet the clinical manifestation of disease in milk allergy (MA) and EoE are distinct. OBJECTIVE To identify CD4+ T cell differences between EoE and MA that may be responsible for distinct disease manifestations
-
JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-04 Simran Samra,Jenna R E Bergerson,Alexandra F Freeman,Stuart E Turvey
The Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling cascade is an evolutionarily conserved signal transduction pathway that regulates many vital cellular processes, including immune function and hematopoiesis. Human genetic variants that disrupt JAK-STAT signaling are being found to cause a rapidly increasing number of diseases, including both germline-encoded inborn
-
Opportunities for using artificial intelligence in air pollution and health research. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-03 Roger D Peng,Sarah E Chambliss
-
Clinical effectiveness and safety of dupilumab in patients with chronic obstructive pulmonary disease: A 7-year population-based cohort study. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-03 Chuan-Yen Sun,Yohannes Tesfaigzi,Gin-Yi Lee,Yi-Hsuan Chen,Scott T Weiss,Kevin Sheng-Kai Ma
BACKGROUND Previous randomized controlled trials have established the efficacy of dupilumab among patients with chronic obstructive pulmonary disease (COPD) treated with triple therapy over 52 weeks of follow-up. OBJECTIVE This population-based cohort study aimed to explore the long-term safety and effectiveness of dupilumab in patients with COPD. METHODS The study included US patients with COPD who
-
Role of anti-IgE in immediate drug allergy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-02 Lily Li,Kimberly G Blumenthal
-
Obesity and Hormonal Influences on Asthma: Mechanisms, Management Challenges, and Emerging Therapeutic Strategies. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-01 Natalia Weare-Regales,Tara Carr,Fernando Holguin,Christopher Andrew Tibbitt,Richard F Lockey
Obesity and hormonal dysregulation, common comorbidities of asthma, not only influence asthma risk and onset but can also complicate its management. The pathobiological characteristics of obesity, such as insulin resistance and metabolism alterations, can impact lung function and airway inflammation while highlighting potential opportunities for therapeutic intervention. Likewise, obesity alters immune
-
Air pollution is associated with persistent peanut allergy in the first 10 years. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-30 Diego J Lopez,Caroline J Lodge,Dinh S Bui,Nilakshi T Waidyatillake,John C Su,Luke D Knibbs,Rushani Wijesuriya,Kirsten P Perrett,Jennifer J Koplin,Victoria X Soriano,Kate Lycett,Yichao Wang,Katie Allen,Suzanne Mavoa,Shyamali C Dharmage,Adrian J Lowe,Rachel L Peters,
BACKGROUND The role of air pollution in eczema and food allergy development remains understudied. OBJECTIVE We aimed to assess whether exposure to air pollution is associated with eczema and food allergies in the first 10 years of life. METHODS HealthNuts recruited a population-based sample of 1-year-old infants who were followed up at ages 4, 6, and 10 years. Annual average fine particulate matter
-
Persistent desmoglein-1 downregulation and periostin accumulation in histologic remission of eosinophilic esophagitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-27 Hannes Hoelz,Tim Faro,Marie-Luise Frank,Ignasi Forné,Daniela Kugelmann,Anja Jurk,Simon Buehler,Kolja Siebert,Monica Matchado,Tobias Straub,Annett Hering,Guido Piontek,Susanna Mueller,Sibylle Koletzko,Markus List,Katja Steiger,Martina Rudelius,Jens Waschke,Tobias Schwerd
BACKGROUND Patients with eosinophilic esophagitis (EoE) require long-lasting resolution of inflammation to prevent fibrostenosis and dysphagia. However, the dissociation between symptoms and histologic improvement suggests persistent molecular drivers despite histologic remission. OBJECTIVE We characterized persisting molecular alterations in pediatric patients with EoE using tissue transcriptomics
-
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-27 H Mark Kenney,Takeshi Yoshida,Evgeny Berdyshev,Agustin Calatroni,Steven R Gill,Eric L Simpson,Stephanie Lussier,Mark Boguniewicz,Tissa Hata,Zelma C Chiesa Fuxench,Anna De Benedetto,Peck Y Ong,Justin Ko,Wendy Davidson,Gloria David,Patrick M Schlievert,Donald Y M Leung,Lisa A Beck
BACKGROUND Atopic dermatitis (AD) is an inflammatory skin condition characterized by widely variable cutaneous Staphylococcus aureus abundance that contributes to disease severity and rapidly responds to type 2 immune blockade (ie, dupilumab). The molecular mechanisms regulating S aureus levels between AD subjects remain poorly understood. OBJECTIVE We investigated host genes that may be predictive
-
Important molecular differences between therapeutic IL-6 receptor inhibition and its genetic mimicry in patients with AD. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-27 Christoph Garbers,Thomas Werfel
-
Deconstructing inflammatory memory across tissue set points using cell circuit motifs. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-26 Andrew C Kwong,Jose Ordovas-Montanes
Tissue ecosystems are cellular communities that maintain set points through a network of intercellular interactions. We position health and chronic inflammatory disease as alternative stable set points that are (1) robust to perturbation and (2) capable of adaptation and memory. Inflammatory memory, which is the storage of prior experience to durably influence future responsiveness, is central to how
-
Cough and itch: Common mechanisms of irritation in the throat and skin. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-23 Sarah G Brooks,Jenny King,Jaclyn Ann Smith,Gil Yosipovitch
Cough and itch are protective mechanisms in the body. Cough occurs as a reflex motor response to foreign body inhalation, while itch is a sensation that similarly evokes a scratch response to remove irritants from the skin. Both cough and itch can last for sustained periods, leading to debilitating chronic disorders that negatively impact quality of life. Understanding the parallels and differences
-
Why EoE is different: Liminality and parent-reported outcomes in food allergy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-23 Paul J Turner
-
Mucosal trained immunity-based vaccines: Cutting recurrent infections in autoimmune patients on immunosuppression. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-21 Gloria Candelas,Ángela Villegas,Silvia Sánchez-Ramón
-
Beyond IL-5 inhibition for the treatment of episodic angioedema with eosinophilia (Gleich syndrome). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-21 Emmanuel Ledoult,Matthieu Groh,Jean-Emmanuel Kahn,Guillaume Lefevre
-
Mepolizumab for episodic angioedema with eosinophilia. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-21 Matthew A Rank
-
Clinical and molecular analysis of longitudinal rhinitis phenotypes in an urban birth cohort. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-20 Sima K Ramratnam,Molly Johnson,Cynthia M Visness,Agustin Calatroni,Mathew C Altman,Tomasz Janczyk,Kathryn E McCauley,Claire Schachtschneider,Kei E Fujimura,Douglas W Fadrosh,Susan V Lynch,Leonard B Bacharier,George T O'Connor,Megan T Sandel,Meyer Kattan,Robert A Wood,Peter J Gergen,Daniel J Jackson,Alkis Togias,James E Gern,
BACKGROUND Chronic rhinitis symptoms cause significant health burden among children and can have a heterogeneous presentation. Defining phenotypes of childhood chronic rhinitis and associated pathobiology may lead to prevention or improved treatments. OBJECTIVES We sought to identify longitudinal patterns of rhinitis symptoms in childhood and determine their associations with early life risk factors
-
Trained immunity-based vaccines for infections and allergic diseases. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-18 Leticia Martín-Cruz,Cristina Benito-Villalvilla,Alba Angelina,José Luis Subiza,Oscar Palomares
Trained immunity has emerged as a new concept in immunology that is associated with the memory of innate immune cells and linked to specific metabolic and epigenetic reprogramming of these cells. Trained immunity may confer nonspecific and sustained protection against a broad range of pathogens, and recent findings show that it might also be involved in allergy mechanisms. Some conventional vaccines
-
European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-18 Alexandra Y Kreins,Fatima Dhalla,Aisling M Flinn,Evey Howley,Olov Ekwall,Anna Villa,Frank J T Staal,Graham Anderson,Andrew R Gennery,Georg A Holländer,E Graham Davies,
Congenital athymia is a life-limiting disorder due to rare inborn errors of immunity causing impaired thymus organogenesis or abnormal thymic stromal cell development and function. Athymic infants have a T-lymphocyte-negative, B-lymphocyte-positive, natural killer cell-positive immunophenotype with profound T-lymphocyte deficiency and are susceptible to severe infections and autoimmunity. Patients
-
Serum cytokine panels in pediatric clinical practice. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-09-18 Paul M Gallo,Jihwan Kim,Kevin O McNerney,Caroline Diorio,Caelin Foley,Laura Kagami,Kristina Wagner,Whitney L Petrosa,Hana Conlon,Kandace L Gollomp,Scott W Canna,Alix E Seif,Maire A Conrad,Judith R Kelsen,Neil Romberg,Hamid Bassiri,Kathleen E Sullivan,David T Teachey,Michele E Paessler,Edward M Behrens,Michele P Lambert
BACKGROUND Cytokines are soluble signaling proteins that regulate inflammation and coordinate immune responses. Serum cytokine panels are increasingly used in medical practice, yet our understanding of cytokines as biomarkers for disease remains limited. OBJECTIVE We sought to analyze real-world single-center use of a multiplexed cytokine panel, correlate its results with diagnosis and severity, and